Authors
Latest:
New Commercial Model: Fact Vs. FictionBelief that today’s commercial model is “broken” elicits a wide range of responses from industry
Latest:
The Five Things We Need to Do to Re-invent Commercial OperationsBy running Commercial Operations like a stand-alone business, executives can sharpen their focus on strategy, tactics and overall performance
Latest:
Puerto Rico is poised for a greater supply chain roleFive reasons why the island can serve as key cog in the national medical supply chain
Latest:
Overcoming operational silos in pharma revenue managementDisconnected business processes in contract administration, managed markets, rebates, sales compensation and related areas cause waste and inefficiency for company management
Latest:
Specialty Pharmacy Providers Deserve Their Own Class of TradeThe emergence of specialty pharmacies, with fundamental differences from other types of pharmacy providers, warrants the establishment of manufacturer relationships
Latest:
Pragmatic randomized clinical trials: Real-world evidence made for payers and regulatorsA complement to the classic randomized clinical trial may benefit drug commercialization
Latest:
Pharma, FDA Wrestle with Social Media ToolsHealthcare discussions are booming on the Internet. How will FDA allow pharma to participate?
Latest:
Managing supply chains from the cloudNew IT data-science and visualization tools advance supply chain management
Latest:
The Time Is Right to Reform Your Approach to Managed CareNot all managed care plans have the same influence on overall prescribing behavior, and not all geographies operate the same way
Latest:
What manufacturers should anticipate when working with specialty pharmaciesWhen entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully
Latest:
Improving medication adherence with technologyThe longstanding adherence problem is yielding to new technology
Latest:
Using patient journey insights to tailor delivery of servicesDeep analysis of specialty pharmacy data shows opportunities for managing the patient journey
Latest:
Varcode to Work with Avery Dennison on a Cold Chain Tracking ApplicationVarcode’s variable barcode records temperature and time out-of-compliance for pharma and perishables
Latest:
The power of strategic data standardizationGlobal efforts to collect clinical data in a more standardized form will lead to more research innovation
Latest:
Is your corporate board equipped to monitor incentive programs?Compliance officers at pharma companies need to ensure that the right mechanisms are in place for monitoring sales and business incentives
Latest:
Advances in clinical trial logisticsBetter local resources around the world and more sophisticated technology are changing the dynamics of logistics services
Latest:
Specialty pharmacy dynamicsThe SP channel continues to grow, with manufacturers looking for more control over access
Latest:
Bringing value to healthcare: practical steps for getting to a market-based modelA new, market-driven model of drug development and commercialization is appearing*
Latest:
DME competitive bidding issues: When is enough enough?Retailers, distributors and manufacturers are being affected by federal rules on durable medical equipment (DME)
Latest:
What Makes a Pharmaceutical Industry Leader?Personality assessments identify the traits that enable some pharma researchers to ascend to leadership roles in industry
Latest:
The end or just the beginning? Exploring federal preemption of state marketing and distribution lawsMultiplying state laws on marketing and distribution disclosures might be pre-empted by new federal legislation
Latest:
Future look: The Impact of Biosimilars on OncologyMarketing strategies will adjust with the advent of biosimilars
Latest:
A managed services approach to sales and marketingApplying the managed services model to commercial operations can result in dramatic savings as pharma companies globalize
Latest:
The end or just the beginning? Exploring federal preemption of state marketing and distribution lawsMultiplying state laws on marketing and distribution disclosures might be pre-empted by new federal legislation
